DPPC-d4
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


DPPC-d4
Description:
DPPC-d4 is deuterium labeled DPPC. DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in mProduct Name Alternative:
129Y83-d4UNSPSC:
12352211Hazard Statement:
H302, H315, H319, H331, H336, H351, H361, H372, H412Target:
Endogenous Metabolite; Isotope-Labeled CompoundsType:
Isotope-Labeled CompoundsRelated Pathways:
Metabolic Enzyme/Protease; OthersApplications:
Metabolism-protein/nucleotide metabolismField of Research:
OthersPurity:
99Solubility:
Ethanol : 25 mg/mL (ultrasonic; warming)Smiles:
CCCCCCCCCCCCCCCC(OC[C@@H](OC(CCCCCCCCCCCCCCC)=O)COP(OC([2H])([2H])C([2H])([N+](C)(C)C)[2H])([O-])=O)=OMolecular Formula:
C40H76D4NO8PMolecular Weight:
738.06Precautions:
H302, H315, H319, H331, H336, H351, H361, H372, H412References & Citations:
[1]Miller AD. Delivery of RNAi therapeutics: work in progress. Expert Rev Med Devices. 2013 Nov;10 (6) :781-811.|[2]Akiko Uemura, et al. Induction of immune responses against glycosphingolipid antigens: comparison of antibody responses in mice immunized with antigen associated with liposomes prepared from various phospholipids. J Vet Med Sci. 2005 Dec;67 (12) :1197-201.|[3]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-223.Shipping Conditions:
Blue IceStorage Conditions:
-20°C, 3 years (Powder)Scientific Category:
Isotope-Labeled CompoundsClinical Information:
No Development ReportedCAS Number:
326495-33-4
